Paloma Partners’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Paloma Partners’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,460	Closed	-$24K	–	2380
2021 Q4	$24K	Buy	+10,460	New	+$26.3K	﹤0.01%	1849
2018 Q4	–	Sell	-18,200	Closed	-$49K	–	1873
2018 Q3	$49K	Buy	+18,200	New	+$37.7K	﹤0.01%	1473
2017 Q3	–	Sell	-183,000	Closed	-$287K	–	2534
2017 Q2	$287K	Buy	+183,000	New	+$353K	﹤0.01%	1817
2017 Q1	–	Sell	-32,171	Closed	-$43K	–	2308
2016 Q4	$43K	Buy	+32,171	New	+$42K	﹤0.01%	1934
2015 Q3	–	Sell	-33,500	Closed	-$367K	–	2010
2015 Q2	$367K	Sell	33,500 -1,446	-4%	-$18.6K	0.01%	1233
2015 Q1	$488K	Buy	34,946 +24,846	+246%	+$380K	0.01%	796
2014 Q4	$171K	Buy	+10,100	New	+$147K	0.01%	1029

Other funds holding INFI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Paloma Partners's INFI Position: Q1 2022 in Review

Paloma Partners sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2022, closing a stake of 10,460 shares — an estimated $24K sold.

Paloma Partners first reported a position in INFI in Q4 2014 and held it in 7 quarters. The position peaked at $488K in Q1 2015. 93 funds tracked by Wall St. Rank hold INFI as of Q1 2022.

Paloma Partners reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2022 after selling out during the quarter.
Paloma Partners sold 10,460 Infinity Pharmaceuticals, Inc. shares in Q1 2022, an estimated $24K.
Paloma Partners first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2014 and held it in 7 quarters.
Paloma Partners's Infinity Pharmaceuticals, Inc. position peaked at $488K in Q1 2015.
93 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2022.

Based on Paloma Partners's 13F filing for Q1 2022, filed 16 May 2022.